A detailed history of Citizens National Bank Trust Department transactions in Novartis Ag stock. As of the latest transaction made, Citizens National Bank Trust Department holds 925 shares of NVS stock, worth $101,694. This represents 0.02% of its overall portfolio holdings.

Number of Shares
925
Previous 925 -0.0%
Holding current value
$101,694
Previous $93,000 4.3%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

BUY
$79.7 - $88.13 $73,722 - $81,520
925 New
925 $81,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $236B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Citizens National Bank Trust Department Portfolio

Follow Citizens National Bank Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Citizens National Bank Trust Department with notifications on news.